Joel Jean-Mairet

Joel Jean-Mairet is a seasoned life sciences investor and entrepreneur with a track record of regulatory approval for 4 drugs and 5 medical devices. As the co-founder and CEO of Glycart (now Roche), he played a pivotal role in the discovery and early development of GA101/Gazyva, the first-ever Breakthrough Designated Drug approved by the FDA in 2013. With a passion for innovation, Joel has held ke...